Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00517621
Status:
COMPLETED
Last Update Posted:
2011-02-25
First Post:
2007-08-16
Brief Title:
Use of FACT-GOGNTX Questionnaire in Peripheral Neurotoxicity Validation of a French Version of This Questionnaire
Sponsor:
ARCAGY GINECO GROUP
Organization:
ARCAGY GINECO GROUP
Study Overview
Official Title:
A Multicenter Prospective Phase II Study Evaluating Peripheral Neurotoxicity by Using FACT-GOGNTX Questionnaire in Patients With Ovarian Cancer in Relapse Treated by Paclitaxel - EPO Validation of a French Version of This Questionnaire
Status:
COMPLETED
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
validation of a french version of FACT-GOGNTX and using this questionnaire to evaluate the incidence of the peripheral neurotoxicity in patients treated for ovarian cancer with paclitaxel associated or not with EPO
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None